Martin Hessing, PhD, General Manager, has a background in Biochemistry and Haematology-Immunology from Utrecht University and held postdoc positions at Kyushu University in Japan and Sanquin in Amsterdam. He obtained work and management experience at the TNO-Nutrition and Food Research Institute and Organon Teknika (now Biomerieux) industry. In 2000, he was co-founder of AM-Pharma, a biopharmaceutical company on protein therapeutics with anti-infectives and sepsis and lead compounds entering Clinical Phase 3. In addition, Martin was involved as co-founder in BiOrion, Microdish, SERPINx and U-PACT and in a number of other biotech start-up companies in various positions. He is co-author of over 50 peer-reviewed papers and 7 patent applications. Martin was co-founder of U-Protein Express BV and sold the business to IPA.